Recall Enforment Report D-1584-2014

Recall Details

Drug Recall Enforcement Report Class III voluntary initiated by Taro Pharmaceuticals U.S.A., Inc., originally initiated on 08-25-2014 for the product Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd., Haifa Bay, Israel 26110. Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3. The product was recalled due to failed content uniformity specifications.. The product was distributed in United States Including: Oh, Hi, Nh, Ms, Il, Tx, Ca. and the recall is currently terminated.

Field Name Field Value
Event ID 69075 What is the Event ID?
A numerical designation assigned by FDA to a specific recall event (used for tracking purposes).
Recall Number D-1584-2014 What is the Recall Number?
An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes).
Recall Classification Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. What is the Recall Classification?
Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified".
Distribution Pattern United States including: OH, HI, NH, MS, IL, TX, CA. What is the Distribution Pattern?
General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included.
Product Description Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd., Haifa Bay, Israel 26110. Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.
Reason For Recall Failed Content Uniformity Specifications. What is the Reason for Recall?
Information describing how the product is defective.
Product Quantity 1396 Bottles Product Quantity
The amount of product subject to recall.
Voluntary Mandated Voluntary: Firm initiated Voluntary / Mandated
Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order.
Report Date 09-24-2014
Recall Initiation Date 08-25-2014 What is the Recall Initiation Date?
The date that the firm first began notifying the public or their consignees of the recall.
Termination Date 05-18-2018 What is the Date Terminated?
The date that FDA terminated the recall.
Initial Firm Notification Letter Initial Firm Notification of Consignee or Public
The method(s) by which the firm initially notified the public or their consignees of a recall.
Product Type Drugs
Recalling Firm Taro Pharmaceuticals U.S.A., Inc.
Code Info Lot #: 149400, Expiry: January 2016; Lot #: 149649, Expiry: January 2016. Code Information
A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling.
Recalled NDC Packages 51672-4027-1; 51672-4027-3; 51672-4027-7; 51672-4027-0; 51672-4028-1; 51672-4028-3; 51672-4028-7; 51672-4028-0; 51672-4029-1; 51672-4029-3; 51672-4029-7; 51672-4029-0; 51672-4030-1; 51672-4030-3; 51672-4030-7; 51672-4030-0; 51672-4031-1; 51672-4031-3; 51672-4031-7; 51672-4031-0; 51672-4032-1; 51672-4032-3; 51672-4032-7; 51672-4032-0; 51672-4033-1; 51672-4033-3; 51672-4033-7; 51672-4033-0; 51672-4034-1; 51672-4034-3; 51672-4034-0; 51672-4035-1; 51672-4035-3; 51672-4035-0
Status Terminated - A recall where FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
51672-4027Warfarin Sodium Warfarin SodiumTabletOralSun Pharmaceutical Industries, Inc.Human Prescription Drug
51672-4028Warfarin Sodium Warfarin SodiumTabletOralSun Pharmaceutical Industries, Inc.Human Prescription Drug
51672-4029Warfarin Sodium Warfarin SodiumTabletOralSun Pharmaceutical Industries, Inc.Human Prescription Drug
51672-4030Warfarin Sodium Warfarin SodiumTabletOralSun Pharmaceutical Industries, Inc.Human Prescription Drug
51672-4031Warfarin Sodium Warfarin SodiumTabletOralSun Pharmaceutical Industries, Inc.Human Prescription Drug
51672-4032Warfarin Sodium Warfarin SodiumTabletOralSun Pharmaceutical Industries, Inc.Human Prescription Drug
51672-4033Warfarin Sodium Warfarin SodiumTabletOralSun Pharmaceutical Industries, Inc.Human Prescription Drug
51672-4034Warfarin Sodium Warfarin SodiumTabletOralSun Pharmaceutical Industries, Inc.Human Prescription Drug
51672-4035Warfarin Sodium Warfarin SodiumTabletOralSun Pharmaceutical Industries, Inc.Human Prescription Drug